anti-TNF therapy (180 Life Sciences)

N/A

Report date: 2025/06/11 11:24:08

Base Information

Drug Nameanti-TNF therapy (180 Life Sciences)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor modulators
TargetsTumor necrosis factor
Therapy Area/IndicationsInflammationColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies180 Life Sciences Corp
China Registration ClassN/A

Develop Information

Active Companies180 Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsInflammationColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A